Sensus Healthcare Files 8-K on Shareholder Votes

TL;DR

Sensus Healthcare held a shareholder vote on May 31st. Details to follow.

AI Summary

Sensus Healthcare, Inc. filed an 8-K on June 5, 2024, reporting on matters submitted to a vote of security holders as of May 31, 2024. The filing details the company's principal executive offices located at 851 Broken Sound Parkway NW, Suite 215, Boca Raton, Florida, 33487.

Why It Matters

This filing indicates that Sensus Healthcare held a vote of its security holders, which could pertain to significant corporate actions or governance matters.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a shareholder vote and does not contain information about financial distress or significant negative events.

Key Players & Entities

• Sensus Healthcare, Inc. (company) — Registrant
• May 31, 2024 (date) — Date of earliest event reported
• June 5, 2024 (date) — Date of Report
• 851 Broken Sound Parkway NW, Suite 215, Boca Raton, Florida, 33487 (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01 per share SRTS Nasdaq Stock Market,

Filing Documents

• ea0207351-8k_sensus.htm (8-K) — 34KB
• 0001213900-24-050044.txt ( ) — 205KB
• srts-20240531.xsd (EX-101.SCH) — 3KB
• srts-20240531_lab.xml (EX-101.LAB) — 33KB
• srts-20240531_pre.xml (EX-101.PRE) — 22KB
• ea0207351-8k_sensus_htm.xml (XML) — 4KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders The Annual Meeting of Stockholders (the " Annual Meeting ") of Sensus Healthcare, Inc, (the " Company ") was held on May 31, 2024. Proxies for the Annual Meeting were solicited pursuant to Regulation 14A under the Securities Exchange Act of 1934, and there was no solicitation in opposition to the Company's solicitation. The following summarizes all matters voted on at the Annual Meeting. 1. Election of Directors . Megan Cornish and Joseph Sardano were elected as Class III directors for a three-year term to expire in 2027 or until their respective successors are elected and qualified. Each nominee was an incumbent director, and no other person was nominated. The tabulation of votes cast was as follows: For Against Abstention Broker Non-Votes Megan Cornish 8,588,606 666,421 127,971 4,108,050 Joseph Sardano 8,789,668 563,106 30,224 4,108,050 2. Amendment of the Company's Amended and Restated Certificate of Incorporation . Stockholders approved an amendment of the Company's Amended and Restated Certificate of Incorporation to permit the exculpation of officers in certain circumstances, as permitted by Delaware law. The tabulation of votes cast was as follows: For Against Abstention Broker Non-Votes 8,795,359 251,690 335,949 4,108,050 3. Advisory Vote on Executive Compensation . Stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers for 2023. The tabulation of votes cast was as follows: For Against Abstention Broker Non-Votes 8,552,812 416,554 413,632 4,108,050 4. Auditor Appointment Ratification . Stockholders ratified the appointment of Marcum LLP as the Company's independent registered public accountant for the fiscal year ended December 31, 2024. The tabulation of votes cast was as follows: For Against Abstention 13,111,490 52,543 327,015 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SENSUS HEALTHCARE, INC. Date: June 5, 2024 By: /s/ Javier Rampolla Javier Rampolla Chief Financial Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR